FindTrial
Sign In

Influence of age on the recovery of TOF after continuous infusion of rocuronium

the Pharmacodynamic of rocuronium after continuous infusion with patients in different ages

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-14005044
Enrollment
Unknown
Registered
2014-08-03
Start date
2014-08-03
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical patients

Interventions

Case series:Electrical stimulation

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ASA I-II grade, no neuromuscular diseases, unused affect neuromuscular system;System functions drugs, liver, kidney function was normal, no severe complications, BMI at 18-26, preoperative water, electrolyte and acid-base balance disorders.

Exclusion criteria

Exclusion criteria: Abnormal liver function; Aqueous electrolyte, acid-base balance disorders; Cardiopulmonary function was abnormal; Neuromuscular function disorder or disease; The use of neuromuscular drugs Bromide known allergy or allergic; pregnant or lactating women; Surgery prodrug; Unnormal temperature; Expected intubation difficult patients.

Design outcomes

Primary

MeasureTime frame
Recovery Index;—

Countries

China

Contacts

Public ContactZhang Huan
382479826@qq.com+86 15210810216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026